Skip to content
10-K

Annual Report

FUSE MEDICAL, INC. FZMD

0001564590-23-005716

← back to feed
Filed
Apr 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 21, 2023 73.9M sh
Shares Diluted FY 2022 · Dec 31, 2022 77.86M sh
Shares Diluted FY 2022 · Dec 31, 2021 70.32M sh
Operating Cash Flow FY 2022 · Dec 31, 2022 $34.8K
Operating Cash Flow FY 2022 · Dec 31, 2021 −$1.78M
Cash And Equivalents FY 2022 · Dec 31, 2022 $147.85K
Cash And Equivalents FY 2022 · Dec 31, 2021 $553.19K
Stockholders Equity FY 2022 · Dec 31, 2022 −$310.85K
Stockholders Equity FY 2022 · Dec 31, 2021 −$3.43M
Stockholders Equity FY 2022 · Dec 31, 2020 −$2.11M
Current Liabilities FY 2022 · Dec 31, 2022 $12.39M
Current Liabilities FY 2022 · Dec 31, 2021 $9.94M
Total Liabilities FY 2022 · Dec 31, 2022 $20.07M
Total Liabilities FY 2022 · Dec 31, 2021 $21.74M
Current Assets FY 2022 · Dec 31, 2022 $13.77M
Current Assets FY 2022 · Dec 31, 2021 $12.82M
Total Assets FY 2022 · Dec 31, 2022 $19.76M
Total Assets FY 2022 · Dec 31, 2021 $18.3M
Eps Diluted FY 2022 · Dec 31, 2022 $0.04
Eps Diluted FY 2022 · Dec 31, 2021 −$0.02
Eps Basic FY 2022 · Dec 31, 2022 $0.04
Eps Basic FY 2022 · Dec 31, 2021 −$0.02
Sga Expense FY 2022 · Dec 31, 2022 $6.54M
Sga Expense FY 2022 · Dec 31, 2021 $7.01M
Net Income FY 2022 · Dec 31, 2022 $3.1M
Net Income FY 2022 · Dec 31, 2021 −$1.59M
Operating Income FY 2022 · Dec 31, 2022 −$815.07K
Operating Income FY 2022 · Dec 31, 2021 −$2.2M
Gross Profit FY 2022 · Dec 31, 2022 $11.54M
Gross Profit FY 2022 · Dec 31, 2021 $11.94M
Cost Of Revenue FY 2022 · Dec 31, 2022 $7.1M
Cost Of Revenue FY 2022 · Dec 31, 2021 $8.48M
Revenue FY 2022 · Dec 31, 2022 $18.64M
Revenue FY 2022 · Dec 31, 2021 $20.41M